10-K/A

FORM 10-K/A

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: March 24, 2021
Period of Report: December 31, 2020
Accession Number: 0001437749-21-007035

View Document ↗ View on SEC.gov ↗